The Board of Directors adopted the Second Amended and Restated Bylaws, effective October 12, 2026. The changes revise Section 2.6 to clarify that any matter other than director elections brought before a stockholder meeting will be decided by the affirmative vote of holders of a majority in voting power of votes cast, excluding broker non-votes and abstentions. This governance update standardizes the voting threshold for routine corporate actions. Intelligent Bio Solutions Inc. operates as a biotechnology company focused on developing therapeutic products.
